TFDP3 confers chemoresistance in minimal residual disease within childhood T-cell acute lymphoblastic leukemia

Acquired drug resistance in childhood T-cell acute lymphoblastic leukemia (T-ALL) remains a significant clinical problem. In this study, a novel gene therapy target for childhood T-ALL to overcome chemoresistance was discovered: TFDP3 increased in the minimal residual disease (MRD) positive childhoo...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Ming, Yin, Kailin, Dong, Yujun, Wang, Pingzhang, Xue, Yun, Zhou, Peng, Wang, Yuqi, Wang, Yuedan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352064/
https://www.ncbi.nlm.nih.gov/pubmed/27902457
http://dx.doi.org/10.18632/oncotarget.13630

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352064/
https://www.ncbi.nlm.nih.gov/pubmed/27902457
http://dx.doi.org/10.18632/oncotarget.13630

Ejemplares similares